NexgenRX Inc. Total Liabilities

Latest as of September 2025: CA$30.91 Million CAD ≈ $22.36 Million USD

NexgenRX Inc. total liabilities. Based on the latest financial reports, NexgenRX Inc. (NXG) has total liabilities worth CA$30.91 Million CAD (≈ $22.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See NXG days of operational coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of NexgenRX Inc. (2013–2024)

Total liabilities of NexgenRX Inc. from 2013 to 2024. This chart illustrates how NexgenRX Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore NexgenRX Inc. long-term investment allocation to see how much of total assets are deployed in long-term investments.

NexgenRX Inc. Competitors by Total Liabilities

The table below lists competitors of NexgenRX Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
Cosmos Technology International Berhad KLSE:0261	Malaysia	RM13.10 Million
Desoto Resources Ltd AU:DES	Australia	AU$462.95K
Carimin Petroleum Bhd KLSE:5257	Malaysia	RM114.60 Million
Cubic Digital Technology Co Ltd SHE:300344	China	CN¥144.52 Million
Hammerson PLC LSE:HMSO	UK	GBX1.73 Billion
Papilon Savunma Guvenlik Sistemleri IS:PAPIL	Turkey	TL43.59 Million
Vection Technologies Ltd AU:VR1	Australia	AU$55.72 Million
WOOJUNG BIO Inc KQ:215380	Korea	₩76.72 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down NexgenRX Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NexgenRX Inc. asset portfolio.

Liquidity & Leverage Metrics

NexgenRX Inc. Total Liabilities Ratios Explained

NexgenRX Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NexgenRX Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NexgenRX Inc. (2013–2024)

The table below shows the annual total liabilities of NexgenRX Inc. from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$22.84 Million ≈ $16.52 Million	+1.60%
2023-12-31	CA$22.48 Million ≈ $16.26 Million	+33.06%
2022-12-31	CA$16.90 Million ≈ $12.22 Million	-14.33%
2021-12-31	CA$19.72 Million ≈ $14.27 Million	0.00%
2020-12-31	CA$19.72 Million ≈ $14.27 Million	+1.91%
2019-12-31	CA$19.35 Million ≈ $14.00 Million	+20.46%
2018-12-31	CA$16.07 Million ≈ $11.62 Million	+108.48%
2017-12-31	CA$7.71 Million ≈ $5.57 Million	+3.75%
2016-12-31	CA$7.43 Million ≈ $5.37 Million	+11.78%
2015-12-31	CA$6.64 Million ≈ $4.81 Million	+462.28%
2014-12-31	CA$1.18 Million ≈ $854.86K	-13.94%
2013-12-31	CA$1.37 Million ≈ $993.35K	--

About NexgenRX Inc.

V:NXG Canada Health Information Services

Market Cap

$33.95 Million

CA$46.94 Million CAD

Market Cap Rank

#24458 Global

#919 in Canada

Share Price

CA$0.66

Change (1 day)

-9.59%

52-Week Range

CA$0.31 - CA$0.73

All Time High

CA$0.73